Stay updated with breaking news from Nasdaq Cdmo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avid Bioservices (NASDAQ:CDMO – Get Rating) had its price objective lowered by Stephens from $24.00 to $20.00 in a research report issued to clients and investors on Thursday, The Fly reports. Stephens’ target price suggests a potential upside of 49.93% from the company’s current price. Separately, Royal Bank of Canada reaffirmed an “outperform” rating and […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) Director Richard B. Hancock sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $17.92, for a total value of $89,600.00. Following the transaction, the director now owns 39,134 shares in the company, […]
Geneva Capital Management LLC increased its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) by 27.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,836,781 shares of the biopharmaceutical company’s stock after buying an additional 396,417 shares […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) CEO Nicholas Stewart Green sold 7,000 shares of the firm’s stock in a transaction on Thursday, April 13th. The stock was sold at an average price of $20.92, for a total value of $146,440.00. Following the transaction, the chief executive officer now owns 83,531 shares in the company, […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) was down 6% during mid-day trading on Friday . The stock traded as low as $19.63 and last traded at $19.67. Approximately 237,027 shares were traded during mid-day trading, a decline of 59% from the average daily volume of 584,865 shares. The stock had previously closed at $20.93. […]